Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identifying drug targets for leukaemia

02.05.2016

Researchers from Hong Kong and the U.S. have developed a new statistical and mapping method that could help identify drug targets for treating leukaemia.

In chronic myelogenous leukaemia (CML), too many stem cells in the bone marrow are transformed into a type of white blood cell called granulocytes, making less room for healthy white blood cells, red blood cells and platelets. CML occurs due to a chromosomal abnormality in which an abnormal gene is formed, called the BCR-ABL fusion gene. However, the development of CML is not fully understood, leading to limited treatment options.


The findings could help physicians develop more effective treatment strategies for chronic myelogenous leukaemia.

Copyright : Sebastian Kaulitzki

The BCR-ABL gene activates enzyme pathways that disrupt protein synthesis and cause uncontrolled cell growth. A better understanding of these pathways and how they are activated could lead to the discovery of drug targets for CML.

Past research has shown that the expression of a protein-coding gene called NPM1 changes in tumour cells. NPM1 was found to respond to signals from enzyme pathways initiated by the BCR-ABL gene.

Benjamin Yung’s research group at The Hong Kong Polytechnic University together with researchers from Harvard University in the U.S. and Queen Elizabeth Hospital in Hong Kong have developed a unique statistical and mapping strategy that identifies the relationships among those genes that are involved in the development of CML.

Using their unique statistical approach, the researchers quantified and analysed publicly available gene expression data of nine CML patients and eight healthy volunteers. They created networking maps from the data to facilitate the visualization of the connections among genes.

They compared NPM1 gene expressions with those from the BCR-ABL-initiated enzyme pathways in the CML patients and similar pathways that exist in healthy individuals. They also explored the role of NPM1 “doublets” – genes strongly co-expressed with NPM1 – in protein formation.

The researchers identified two sets of gene doublets that strongly co-expressed in CML patients but were not co-expressed in healthy individuals. These gene pairs may be related to CML development and thus could be an important target for drug research.

They also found that NPM1 established ten gene-expressing pairs with BCR-ABL pathways in CML patients but only two pairs with similar pathways in healthy individuals, which may mean that NPM1 mediates the activation of other cellular proliferation pathways in CML.

Finally, the researchers used a substance, called resveratrol, which is thought to have anti-cancer properties, on CML cells. Resveratrol caused a decrease in the expression of NPM1-related proteins and is thus a potential drug target for CML therapy.

The researchers’ findings could help physicians develop more effective treatment strategies for CML. Their statistical and mapping strategy can also be used to diagnose and develop treatments for other diseases.

For further information contact:

Professor Benjamin Yung
Department of Health Technology and Informatics
The Hong Kong Polytechnic University
E-mail: ben.yung@polyu.edu.hk

Associated links

The Hong Kong Polytechnic University | Research SEA
Further information:
http://www.researchsea.com

More articles from Life Sciences:

nachricht Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex

nachricht New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>